CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia

被引：0
|
作者：
Yao, Yao [1 ,2 ]
Zhou, Jin [1 ,2 ]
Li, Yanting [1 ,2 ]
Shi, Sensen [1 ,2 ]
Yu, Lei [3 ]
Wu, Depei [1 ,2 ]
Wang, Ying [1 ,2 ]
机构：
[1] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2024年
关键词：
YOUNG-ADULTS; CHILDREN;
D O I：
10.1007/s00277-024-05945-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6031 / 6033
页数：3
相关论文
共 50 条
  • [21] Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Kong, Delin
    Geng, Jia
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [22] CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
    Testa, Ugo
    Sica, Simona
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [23] Successful Treatment of TCF3-HLF-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy
    Wang, Tianyi
    Wan, Xinyu
    Yang, Fan
    Shi, Wenhua
    Liu, Rui
    Ding, Lixia
    Tang, Yanjing
    Luo, Chengjuan
    Yang, Xiaomin
    Ma, Yani
    Wang, Xiang
    Liang, Huanhuan
    Li, Benshang
    Lu, Jun
    Chen, Jing
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 386 - 392
  • [24] Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia
    Zhou, Qianyi
    An, Yuxin
    Zhang, Xiaomei
    Xiao, Xia
    Bai, Xue
    Liu, Pengjiang
    Pu, Yedi
    Meng, Juanxia
    Zhu, Haibo
    Lyu, Cuicui
    Zhang, Huan
    Zhang, Yu
    Xie, Tianle
    Meng, Haotian
    Lyu, Hairong
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [25] A comprehensive and integrative omic analysis of multiply relapsed refractory pediatric pre-B cell acute lymphoblastic leukemia predicts response to CD19 CAR T-cell therapy
    Masih, Katherine E.
    Gardner, Rebecca
    Gryder, Berkley E.
    Abdelmaksoud, Abdalla
    Wilson, Ashley
    Adebola, Serifat
    Stanton, Benjamin Z.
    Song, Young K.
    Lack, Justin
    Wang, Chaoyu
    Wen, Xinyu
    Rae, Zachary
    Cheuk, Adam
    Altan-Bonnet, Gregoire
    Kelly, Michael
    Wei, Jun S.
    Jensen, Michael C.
    Orentas, Rimas J.
    Khan, Javed
    CANCER RESEARCH, 2020, 80 (14) : 47 - 47
  • [26] CAR-T Cell Therapy With CRISPR/CAS9 Engineering for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia, With Universal Dual Target CD19/CD22
    Baptista, Gabriel
    Carvalho, Julia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S529 - S529
  • [27] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [28] Efficacy and Safety of Children With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia After Anti-CD19 CAR T-Cell Therapy Without Bridging Transplantation
    Shang, Qianwen
    Xue, Lian
    Lu, Aidong
    Jia, Yueping
    Zuo, YingXi
    Zeng, Huimin
    Zhang, Leping
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (06): : 392 - 399.e5
  • [29] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients With Relapsed or Refractory Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 15 - 17
  • [30] OUTCOMES OF COMMERCIAL AND IN-HOUSE ANTI CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL LYMPHOMA IN SINGAPORE
    Ong, Shin Yeu
    Krisnadi, Cindy
    Wang, Samuel Sherng Young
    Chen, Yun Xin
    Seng, Michaela Su-fern
    Soh, Shui Yen
    Chan, Esther Hian Li
    Hwang, William Ying Khee
    Ho, Aloysius Yew Leng
    Lim, Francesca Lorraine Wei Inng
    BONE MARROW TRANSPLANTATION, 2024, 59 : 226 - 226
12345